Abstract
Summary
Data on the true acute care costs of hip fractures for patients admitted from care homes are limited. Detailed costing analysis was undertaken for 100 patients. Median cost was £9,429 [€10,896], increasing to £14,435 [€16,681], for those requiring an upgrade from residential to nursing home care. Seventy-six percent of costs were attributable to hospital bed days, and therefore, interventions targeted at reducing hospital stay may be cost effective.
Introduction
Previous studies have estimated the costs associated with hip fracture, although these vary widely, and for patients admitted from care homes, who represent a significant fracture burden, there are limited data. The primary aim of this study was to perform a detailed assessment of the direct medical costs incurred and secondly compare this to the actual remuneration received by the hospital.
Methods
One hundred patients presenting from a care home in 2006 were randomly selected and a detailed case-note costing analysis was undertaken. This cost was then compared to the actual remuneration received by the hospital.
Results
Median cost per patient episode was £9,429 [€10,896] (all patients) range £4,292–162,324 [€4,960–187,582] (subdivided into hospital bed day costs £7,129 [€8,238], operative costs £1,323 [€1,529] and investigation costs £977 [€1,129]). Twenty-two percent of the patients admitted from a residential home required upgrading to a nursing home. In this group, the median length of stay was 31 days (mean 38, range 10–88) median cost £14,435 [€16,681]. Average remuneration received equated to £6,222 [€7,190] per patient. This represents a mean loss in income, compared to actual calculated costs of £3,207 [€3,706] per patient.
Conclusion
The median cost was £9,429 [€10,896], increasing to £14,435 [€16,681], for those requiring an upgrade from residential to nursing home care at discharge. Significant cost differences were seen comparing the actual cost to remuneration received. Interventions targeted at reducing length of stay may be cost effective.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dolan P, Torgerson DJ (1988) The cost of treating osteoporosis in the United Kingdom female population. Osteoporos Int 8:611–617
http://www.ccad.org.uk/nhfd.nsf/NHFD_National_Report_Extended_2010.pdf
Campion EW, Jette AM, Cleary PD, Harris BA (1987) Hip fracture: a prospective study of hospital course, complications, and costs. J Gen Intern Med 2(2):78–82
Jacobs MJ, Markel DC (1999) Geriatric intertrochanteric hip fractures: an economic analysis. Am J Orthop 28(10):573–576
Haentjens P, Autier P, Barette P, Boonen S (2003) Costs of care after hospital discharge among women with a femoral neck fracture. Clin Orthop 414:250–258
Wiktorowicz ME, Goeree R, Papaioannou A et al (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12(4):271–278
Borgquist L, Lindelow G, Thorngren KG (1991) Costs of hip fracture. Rehabilitation of 180 patients in primary health care. Acta Orthop Scand 62(1):39–48
Braithwaite RS, Col NF, Wong JB (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51(3):364–370
Lawrence TM, White CT, Wenn R, Moran CG (2005) The current hospital costs of treating hip fractures. Injury 36:88–91
Robbins JA, Donaldson LJ (1984) Analysing stages of care in hospital stay for fractured neck of femur. Lancet 2:1028–1029
Farnworth MG, Kenny P, Shiell A (1994) The costs and effects of early discharge in the management of fractured hip. Age Ageing 23(3):190–194
Hollingworth W, Todd C, Parker M et al (1993) Cost analysis of early discharge after hip fracture. BMJ 307:903–906
DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group (2009) Patient level pooled analysis of 68 < thin > 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 339:b5463
Avenell A, Gillespie WJ, Gillespie LD, O’Connell D (2009) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post menopausal osteoporosis. Cochrane Database Syst Rev;(2):CD000227
Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF (2000) Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419–424
Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: meta-analysis of randomised controlled trials. BMJ 339:b3692
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sahota, O., Morgan, N. & Moran, C.G. The direct cost of acute hip fracture care in care home residents in the UK. Osteoporos Int 23, 917–920 (2012). https://doi.org/10.1007/s00198-011-1651-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-011-1651-9